First Page | Document Content | |
---|---|---|
Date: 2014-05-22 11:31:36Pharmacology Monoclonal antibodies Immune system Immunology Ulcerative colitis TNF inhibitor Mucositis Inflammatory bowel disease Biologic Medicine Health Autoimmune diseases | Avaxia CEO Barbara Fox is Named an EY Entrepreneur Of The Year™ 2014 Award Finalist in New EnglandAdd to Reading ListSource URL: www.avaxiabiologics.comDownload Document from Source WebsiteFile Size: 259,34 KBShare Document on Facebook |